Rolf Marschalek
Overview
Explore the profile of Rolf Marschalek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
182
Citations
2391
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ciurus S, Elewa M, Palmer M, Wolf A, Hector M, Fuhrmann D, et al.
Cell Mol Life Sci
. 2025 Feb;
82(1):85.
PMID: 39985685
Chronic inflammatory diseases are a significant global burden and are associated with dysregulated resolution of inflammation. Therefore, promoting the process of resolution is a promising therapeutic approach. This study presents...
2.
Hyprath M, Molitor M, Schweighofer I, Marschalek R, Steinhilber D
Front Pharmacol
. 2025 Jan;
15:1520507.
PMID: 39877387
5-Lipoxygenase (5-LO), encoded by the gene , is implicated in several pathologies. As key enzyme in leukotriene biosynthesis, 5-LO plays a central role in inflammatory diseases, but the 5-LO pathway...
3.
Benz T, Larghero P, Meyer C, Muller M, Bruggmann D, Hentrich A, et al.
STAR Protoc
. 2024 Dec;
6(1):103481.
PMID: 39700011
KMT2A rearrangements are associated with a poor clinical outcome in infant, pediatric, and adult acute lymphoblastic and myeloid leukemia. Here, we present a protocol to reconstruct chromosomal translocations with different...
4.
Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia
Bardini M, Fazio G, Abascal L, Meyer C, Maglia O, Sala S, et al.
Br J Haematol
. 2024 Aug;
205(5):1883-1888.
PMID: 39099338
Rearrangement of NUTM1 gene (NUTM1r) is one of the most frequent aberrations occurring in infants (younger than 1 year at diagnosis) with B-cell precursor Acute Lymphoblastic Leukaemia (BCP-ALL). In this...
5.
Lopez-Millan B, Rubio-Gayarre A, Vinyoles M, Trincado J, Fraga M, Fernandez-Fuentes N, et al.
Blood
. 2024 Aug;
144(19):2002-2017.
PMID: 39093982
B-cell acute lymphoblastic leukemia (B-ALL) is the most common pediatric cancer, with long-term overall survival rates of ∼85%. However, B-ALL harboring rearrangements of the MLL gene (also known as KMT2A),...
6.
Hovorkova L, Winkowska L, Skorepova J, Krumbholz M, Benesova A, Polivkova V, et al.
Mol Cancer
. 2024 Jul;
23(1):138.
PMID: 38970095
Background: The BCR::ABL1 is a hallmark of chronic myeloid leukemia (CML) and is also found in acute lymphoblastic leukemia (ALL). Most genomic breaks on the BCR side occur in two...
7.
Maurer-Granofszky M, Kohrer S, Fischer S, Schumich A, Nebral K, Larghero P, et al.
Haematologica
. 2024 Jul;
109(7):2379-2381.
PMID: 38946650
No abstract available.
8.
Roesmann F, Sertznig H, Klaassen K, Wilhelm A, Heininger D, Hess S, et al.
J Virol
. 2024 Jun;
98(7):e0053424.
PMID: 38899932
The interplay between host factors and viral components impacts viral replication efficiency profoundly. Members of the cellular heterogeneous nuclear ribonucleoprotein family (hnRNPs) have been extensively studied as HIV-1 host dependency...
9.
Burmeister T, Stroh A, Kehden B, Trautmann H, Meyer C, Marschalek R, et al.
Leukemia
. 2024 Mar;
38(7):1600-1603.
PMID: 38519799
No abstract available.
10.
Zaliova M, Zuna J, Winkowska L, Janotova I, Skorepova J, Lukes J, et al.
Leukemia
. 2023 Nov;
38(1):21-30.
PMID: 38001170
Measurable residual disease (MRD) monitoring in childhood acute myeloid leukemia (AML) is used to assess response to treatment and for early detection of imminent relapse. In childhood AML, MRD is...